A follow-up of integrated positron emission tomography/computed tomography after curative resection of non–small-cell lung cancer in asymptomatic patients

Slides:

Advertisements

Similar presentations

Sukki Cho, MD, Kyung-Min Ryu, MD, Yoon-Jin Hwang, MD, Eung Bae Lee, MD

Advertisements

Lost in translation The Journal of Thoracic and Cardiovascular Surgery

Manuel J. Antunes, MD, PhD, DSc

Stephen R. Broderick, MD, MPHS

PET/CT Fusion Scan in Lung Cancer: Current Recommendations and Innovations Cristina Gámez, MD, PhD, Rafael Rosell, MD, PhD, Alejandro Fernández, MD, PhD,

The eighth edition TNM stage classification for lung cancer: What does it mean on main street? Frank C. Detterbeck, MD The Journal of Thoracic and Cardiovascular.

Characteristics and outcomes of secondary nodules identified on initial computed tomography scan for patients undergoing resection for primary non–small.

One in every 14 patients with early-stage lung cancer is not being treated! Benny Weksler, MD, MBA The Journal of Thoracic and Cardiovascular Surgery

It is not just about surgery versus stereotactic ablative radiotherapy, it is about curing as many patients with lung cancer as possible Alessandro Brunelli,

Effect of tumor size on prognosis in patients with non–small cell lung cancer: The role of segmentectomy as a type of lesser resection Morihito Okada,

Pure ground glass nodular adenocarcinomas: Are preoperative positron emission tomography/computed tomography and brain magnetic resonance imaging useful.

Lung cancer screening: No more excuses

Impact of tumor size on outcomes after anatomic lung resection for stage 1A non–small cell lung cancer based on the current staging system Shamus R.

Ultrasound, endoscopy, and the recurrent nerve

Yih-Leong Chang, MD, Chen-Tu Wu, MD, Yung-Chie Lee, MD, PhD

The prognostic impact of microRNA sequence polymorphisms on the recurrence of patients with completely resected non–small cell lung cancer Kyong-Ah Yoon,

Outcomes of unexpected pathologic N1 and N2 disease after video-assisted thoracic surgery lobectomy for clinical stage I non–small cell lung cancer Hong.

Intrinsic cardiac stem cells are essential for regeneration

Victor van Berkel, MD, PhD

The Journal of Thoracic and Cardiovascular Surgery

Go on-pump or off-pump in diabetic patients?

The lord of the rings Antonio Miceli, MD, PhD

Is tissue the issue? Brian E. Louie, MD, MHA, MPH, FRCSC, FACS

Yang Zhang, MD, Haiquan Chen, MD, PhD

Aditya K. Kaza, MD The Journal of Thoracic and Cardiovascular Surgery

Impact of positive pleural lavage cytology on survival in patients having lung resection for non–small-cell lung cancer: An international individual patient.

It's not “just a shunt” but sometimes it should be…

A first start for lung transplantation?

Stephen R. Broderick, MD, MPHS

Get it right the first time

Navigating the lung for hidden treasure

Osteoblastic Bone Flare on F18-FDG PET in Non-small Cell Lung Cancer (NSCLC) Patients Receiving Bevacizumab in Addition to Standard Chemotherapy Yelena.

Surgery for aortic and mitral valve disease in the United States: A trend of change in surgical practice between 1998 and 2005 Scott D. Barnett, PhD,

Are discordant positron emission tomography and pathological assessments of the mediastinum in non–small cell lung cancer significant? Daniel J. Tandberg,

Historical perspectives of The American Association for Thoracic Surgery: Robert M. Janes, MD ( ) Myunghyun Lee, MD, Vivek Rao, MD, PhD The.

Resection of primary lung cancer with incidental pleural seeding: Seeds of change or reap what you sow? Jules Lin, MD The Journal of Thoracic and Cardiovascular.

Jeevanantham Rajeswaran, PhD, Eugene H. Blackstone, MD

Fenton H. McCarthy, MD, MS, Nimesh D. Desai, MD, PhD

Internal validation of risk models in lung resection surgery: Bootstrap versus training- and-test sampling Alessandro Brunelli, MD, Gaetano Rocco, MD

The Ross procedure: Time to reevaluate the guidelines

Manuel J. Antunes, MD, PhD, DSc

Video-assisted resection for lung cancer results in fewer complications Lunxu Liu, PhD, MD, FRCS The Journal of Thoracic and Cardiovascular Surgery

Antiangiogenesis Induced Tumor Cavitation in Lung Cancer

Passing the torch The Journal of Thoracic and Cardiovascular Surgery

Shunt right or left? Decision 2016

The harder one looks, the more one finds

Multifocal lung cancer within ground glass lesions: Are favorable outcomes consequent to surgical resection or inherent to the disease? Mara B. Antonoff,

Bryan M. Burt, MD The Journal of Thoracic and Cardiovascular Surgery

The Journal of Thoracic and Cardiovascular Surgery

Discussion The Journal of Thoracic and Cardiovascular Surgery

The future of cardiac surgery training: A survival guide

Linda W. Martin, MD, MPH, FCCP, FACS, Gail E

Robert J. Cerfolio, MD, FACS, FCCP, Ayesha S. Bryant, MSPH, MD

Therapeutic R2 resection for pleural mesothelioma

The Journal of Thoracic and Cardiovascular Surgery

“The more things change…”: The challenges ahead

Aritoshi Hattori, MD, Kenji Suzuki, MD

Ryan R. Davies, MD The Journal of Thoracic and Cardiovascular Surgery

More than vital: Who bears the burden?

Energized lung resections

Lung cancer randomized controlled trials should compare stereotactic body radiation therapy with observation, NOT surgery Raja M. Flores, MD The Journal.

Preoperative PFTs: The answer is blowing in the wind

Of mice and men… The Journal of Thoracic and Cardiovascular Surgery

Who should decide margin length in pulmonary excision of lung cancer?

Is there a benefit to continuing with resection of all sites of disease when clinically occult pleural metastases from non–small cell carcinoma are found?

Did you like Terminator 3 better than Terminator 2

Samuel Kim, MD The Journal of Thoracic and Cardiovascular Surgery

A good chimney requires a good sweep

How do we follow up our patients

Reappraise the advanced technique for tumor localization and sentinel lymph node assessment in clinical early-stage non–small cell lung cancer Chengwu.

Presentation transcript:

A follow-up of integrated positron emission tomography/computed tomography after curative resection of non–small-cell lung cancer in asymptomatic patients Sukki Cho, MD, Eung Bae Lee, MD, PhD The Journal of Thoracic and Cardiovascular Surgery Volume 139, Issue 6, Pages 1447-1451 (June 2010) DOI: 10.1016/j.jtcvs.2009.09.055 Copyright © 2010 The American Association for Thoracic Surgery Terms and Conditions

Figure 1 One patient had definite evidence of recurrence, which showed newly developed high and focal hypermetabolic lesions. A, A preoperative integrated PET/CT showed no hypermetabolic lesions except for the primary mass. B, A follow-up integrated PET/CT after curative resection showed hypermetabolism at the right interlobar nodes and left scapula, but there were no symptoms related to these lesions. C, Left scapular lesion was confirmed as metastasis of lung cancer by shoulder MRI. The Journal of Thoracic and Cardiovascular Surgery 2010 139, 1447-1451DOI: (10.1016/j.jtcvs.2009.09.055) Copyright © 2010 The American Association for Thoracic Surgery Terms and Conditions

Figure 2 An asymptomatic patient manifested extrathoracic recurrence without intrathoracic recurrence. A, A follow-up integrated PET/CT after curative resection showed hypermetabolism at the thoracic spine. B, MRI of the spine confirmed bone metastasis of lung cancer. The Journal of Thoracic and Cardiovascular Surgery 2010 139, 1447-1451DOI: (10.1016/j.jtcvs.2009.09.055) Copyright © 2010 The American Association for Thoracic Surgery Terms and Conditions